Taisho Pharmaceutical Holdings Co Ltd (Pre-Merger)

Common Name
Taisho Pharmaceutical
Country
Japan
Sector
N/A
Industry
N/A
Employees
N/A
Ticker
4581
Exchange
TOKYO STOCK EXCHANGE

Taisho Pharmaceutical's Climate Target Data Preview

As of 2023, Taisho Pharmaceutical has disclosed 1 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 1 absolute reduction target, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Taisho Pharmaceutical ’s climate strategy, ambition level, and alignment with global decarbonization goals.

Target TypeScope of TargetUnitTargetTarget Year
Absolute-based Target*
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e)
Copy restricted. Please purchase to unlock this data.
a
2030
*. This target is limited in scope and does not represent the company's full operational or organizational boundaries

Download Taisho Pharmaceutical's Climate Targets data for free

Create your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.

This table provides a simplified preview of selected climate targets data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.

Verified Sources Behind Taisho Pharmaceutical’s Climate Targets Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Taisho Pharmaceutical’s data sources below and access millions more through our Disclosure Search .

Trace every data point back to Taisho Pharmaceutical’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Insights into Taisho Pharmaceutical's Greenhouse Gas Emissions Pathways

As of 2023, Taisho Pharmaceutical has set greenhouse gas (GHG) emissions reduction targets that cover its operational emissions (Scope 1 and 2), but not its value chain emissions (Scope 3). This means its reduction efforts currently focus on direct and purchased energy emissions. a

Does Taisho Pharmaceutical have a target to reduce the emissions from its operations?

As of 2023, Taisho Pharmaceutical has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources. a

Taisho Pharmaceutical's most ambitious operational target is to reduce these emissions by 46% by 2030, compared to a baseline of 56,263 Metric Tonnes of CO2 equivalent (mtCO2e) in 2013. a

As of 2022, Taisho Pharmaceutical is lagging behind on its operational emissions reduction target, having achieved 23.26% of the planned reduction. a

Taisho Pharmaceutical's Operational (Scope 1+2) Emissions Pathway

201320222030015 k30 k45 k60 kBaselineCurrent (-11%)Target 2030 (-46%)
Want Full Access to Taisho Pharmaceutical's Climate Targets Dataset?
Sign Up